156 related articles for article (PubMed ID: 31165385)
1. Imaging Sigma-1 Receptor (S1R) Expression Using Iodine-124-Labeled 1-(4-Iodophenyl)-3-(2-adamantyl)guanidine ([
Gangangari KK; Váradi A; Majumdar S; Larson SM; Pasternak GW; Pillarsetty NK
Mol Imaging Biol; 2020 Apr; 22(2):358-366. PubMed ID: 31165385
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, in vitro binding, and tissue distribution of radioiodinated 2-[125I]N-(N-benzylpiperidin-4-yl)-2-iodo benzamide, 2-[125I]BP: a potential sigma receptor marker for human prostate tumors.
John CS; Gulden ME; Li J; Bowen WD; McAfee JG; Thakur ML
Nucl Med Biol; 1998 Apr; 25(3):189-94. PubMed ID: 9620622
[TBL] [Abstract][Full Text] [Related]
3. Radioiodination and preclinical evaluation of 4-benzyl-1-(3-[
Sadeghzadeh M; Alirezapour B; Charkhlooie GA; Baghery MK; Khorouti A
Ann Nucl Med; 2017 May; 31(4):335-346. PubMed ID: 28315150
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of
Lepelletier FX; Vandesquille M; Asselin MC; Prenant C; Robinson AC; Mann DMA; Green M; Barnett E; Banister SD; Mottinelli M; Mesangeau C; McCurdy CR; Fricke IB; Jacobs AH; Kassiou M; Boutin H
Theranostics; 2020; 10(18):7938-7955. PubMed ID: 32724451
[TBL] [Abstract][Full Text] [Related]
5. Design and Investigation of a [
Yang D; Comeau A; Bowen WD; Mach RH; Ross BD; Hong H; Van Dort ME
Mol Pharm; 2017 Mar; 14(3):770-780. PubMed ID: 28135101
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, in vitro validation and in vivo pharmacokinetics of [125I]N-[2-(4-iodophenyl)ethyl]-N-methyl-2-(1-piperidinyl) ethylamine: a high-affinity ligand for imaging sigma receptor positive tumors.
John CS; Gulden ME; Vilner BJ; Bowen WD
Nucl Med Biol; 1996 Aug; 23(6):761-6. PubMed ID: 8940718
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and in vitro and in vivo evaluation of an (18)F-labeled neuropeptide Y analogue for imaging of breast cancer by PET.
Hofmann S; Maschauer S; Kuwert T; Beck-Sickinger AG; Prante O
Mol Pharm; 2015 Apr; 12(4):1121-30. PubMed ID: 25748228
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, biodistribution and micro-PET imaging of a potential cancer biomarker carbon-11 labeled MMP inhibitor (2R)-2-[[4-(6-fluorohex-1-ynyl)phenyl]sulfonylamino]-3-methylbutyric acid [11C]methyl ester.
Zheng QH; Fei X; DeGrado TR; Wang JQ; Stone KL; Martinez TD; Gay DJ; Baity WL; Mock BH; Glick-Wilson BE; Sullivan ML; Miller KD; Sledge GW; Hutchins GD
Nucl Med Biol; 2003 Oct; 30(7):753-60. PubMed ID: 14499334
[TBL] [Abstract][Full Text] [Related]
9. PET imaging of colorectal cancer in xenograft-bearing mice by use of an 18F-labeled T84.66 anti-carcinoembryonic antigen diabody.
Cai W; Olafsen T; Zhang X; Cao Q; Gambhir SS; Williams LE; Wu AM; Chen X
J Nucl Med; 2007 Feb; 48(2):304-10. PubMed ID: 17268029
[TBL] [Abstract][Full Text] [Related]
10. Radiosynthesis, cerebral distribution, and binding of [125I]-1-(p-iodophenyl)-3-(1-adamantyl)guanidine, a ligand for sigma binding sites.
Kimes AS; Wilson AA; Scheffel U; Campbell BG; London ED
J Med Chem; 1992 Dec; 35(25):4683-9. PubMed ID: 1469697
[TBL] [Abstract][Full Text] [Related]
11. Development of a Tc-99m labeled sigma-2 receptor-specific ligand as a potential breast tumor imaging agent.
Choi SR; Yang B; Plössl K; Chumpradit S; Wey SP; Acton PD; Wheeler K; Mach RH; Kung HF
Nucl Med Biol; 2001 Aug; 28(6):657-66. PubMed ID: 11518647
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a novel iodinated sigma-2 receptor ligand as a cell proliferation marker.
Hou C; Tu Z; Mach R; Kung HF; Kung MP
Nucl Med Biol; 2006 Feb; 33(2):203-9. PubMed ID: 16546674
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and pharmacological characterization of 4-[125I]-N-(N-benzylpiperidin-4-yl)-4-iodobenzamide: a high affinity sigma receptor ligand for potential imaging of breast cancer.
John CS; Vilner BJ; Gulden ME; Efange SM; Langason RB; Moody TW; Bowen WD
Cancer Res; 1995 Jul; 55(14):3022-7. PubMed ID: 7606722
[TBL] [Abstract][Full Text] [Related]
14. Syntheses and evaluation of a homologous series of aza-vesamicol as improved radioiodine-labeled probes for sigma-1 receptor imaging.
Ogawa K; Masuda R; Mishiro K; Wang M; Kozaka T; Shiba K; Kinuya S; Odani A
Bioorg Med Chem; 2019 May; 27(10):1990-1996. PubMed ID: 30975500
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of σ-1 receptor radioligand 18F-FTC-146 in rats and squirrel monkeys using PET.
James ML; Shen B; Nielsen CH; Behera D; Buckmaster CL; Mesangeau C; Zavaleta C; Vuppala PK; Jamalapuram S; Avery BA; Lyons DM; McCurdy CR; Biswal S; Gambhir SS; Chin FT
J Nucl Med; 2014 Jan; 55(1):147-53. PubMed ID: 24337599
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and pre-clinical evaluation of a new class of high-affinity
Kelly J; Amor-Coarasa A; Nikolopoulou A; Kim D; Williams C; Ponnala S; Babich JW
Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):647-661. PubMed ID: 27847991
[TBL] [Abstract][Full Text] [Related]
17. SPECT imaging of neuropilin receptor type-1 expression with 131I-labeled monoclonal antibody.
Dou X; Yan J; Zhang Y; Liu P; Jiang Y; Lv S; Zeng F; Chen X; Wang S; Zhang H; Wu H; Zhang H; Ouyang L; Su X
Int J Oncol; 2016 Sep; 49(3):961-70. PubMed ID: 27315007
[TBL] [Abstract][Full Text] [Related]
18.
Han N; Jiang Y; Gai Y; Liu Q; Yuan L; Wang Y; Li M; Zhang Y; Lan X
Contrast Media Mol Imaging; 2019; 2019():1760184. PubMed ID: 31787861
[TBL] [Abstract][Full Text] [Related]
19. Development of a novel radiobromine-labeled sigma-1 receptor imaging probe.
Ogawa K; Masuda R; Mizuno Y; Makino A; Kozaka T; Kitamura Y; Kiyono Y; Shiba K; Odani A
Nucl Med Biol; 2018 Jun; 61():28-35. PubMed ID: 29704822
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, in vitro pharmacologic characterization, and preclinical evaluation of N-[2-(1'-piperidinyl)ethyl]-3-[125I]iodo-4-methoxybenzamide (P[125I]MBA) for imaging breast cancer.
John CS; Bowen WD; Fisher SJ; Lim BB; Geyer BC; Vilner BJ; Wahl RL
Nucl Med Biol; 1999 May; 26(4):377-82. PubMed ID: 10382840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
